Canada markets close in 4 hours 18 minutes

NexImmune, Inc. (NEXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.3800-0.1100 (-3.15%)
As of 11:14AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.63M
Enterprise Value 56.47k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.00

Trading Information

Stock Price History

Beta (5Y Monthly) 2.06
52-Week Change 3-58.40%
S&P500 52-Week Change 325.59%
52 Week High 328.6950
52 Week Low 31.2500
50-Day Moving Average 34.7284
200-Day Moving Average 35.3487

Share Statistics

Avg Vol (3 month) 369.66k
Avg Vol (10 day) 319.7k
Shares Outstanding 51.37M
Implied Shares Outstanding 61.37M
Float 81.15M
% Held by Insiders 121.94%
% Held by Institutions 18.84%
Shares Short (Apr 15, 2024) 48.12k
Short Ratio (Apr 15, 2024) 40.17
Short % of Float (Apr 15, 2024) 40.66%
Short % of Shares Outstanding (Apr 15, 2024) 40.59%
Shares Short (prior month Mar 15, 2024) 435.21k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Oct 19, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-70.62%
Return on Equity (ttm)-180.64%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.16M
Net Income Avi to Common (ttm)-32.34M
Diluted EPS (ttm)-30.8200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.2M
Total Cash Per Share (mrq)2.34
Total Debt (mrq)68.81k
Total Debt/Equity (mrq)1.96%
Current Ratio (mrq)1.06
Book Value Per Share (mrq)3.29

Cash Flow Statement

Operating Cash Flow (ttm)-31.43M
Levered Free Cash Flow (ttm)-17.9M